Next Science Limited
NXSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.47 | 0.02 | 0.93 | 0.08 |
| FCF Yield | -17.01% | -14.54% | -10.18% | -15.06% |
| EV / EBITDA | -5.05 | -5.14 | -8.90 | -6.65 |
| Quality | ||||
| ROIC | -83.85% | -68.96% | -68.40% | -56.77% |
| Gross Margin | 83.16% | 81.86% | 79.78% | 73.13% |
| Cash Conversion Ratio | 0.59 | 0.62 | 0.86 | 1.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 70.76% | 80.35% | 86.29% | 71.95% |
| Free Cash Flow Growth | 6.00% | 41.34% | 38.74% | -0.58% |
| Safety | ||||
| Net Debt / EBITDA | -1.06 | -0.20 | 0.52 | 1.19 |
| Interest Coverage | -8.14 | -17.59 | -186.62 | -20.30 |
| Efficiency | ||||
| Inventory Turnover | 2.87 | 2.89 | 2.80 | 4.69 |
| Cash Conversion Cycle | -142.13 | 17.28 | -65.09 | 7.30 |